Skip to main content

Table 3 History Comparison between study groups regarding disease duration, activity and medication

From: Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis

 

PsA

(N = 26)

AS

(N = 22)

P value

Duration (year) mean ± SD

5.32 ± 5.61

6.37 ± 4.15

0.735

HLA B27 positive testing N (%)

19 (73.1)

16 (72.7)

0.428

Active disease

RAPID 3 score N (%)

10 (38.5)

9 (41)

0.625

HAQ score N (%)

4 (15.4)

6 (27.2)

Medications

Biologic DMARDs N (%)

21 (80.7)

18(81.8)

0.263

DMARDs N (%)

3 (11.5)

6 (27.2)

NSAIDs N (%)

10 (38.4)

8 (36.3)

Corticosteroids N (%)

11 (42.3)

8 (36.3)

  1. HAQ Health Assessment Questionnaire, RAPID 3 Routine Assessment Patient Index Data with 3 measures, DMARDs Disease-Modifying Anti-Rheumatic Drugs, NSAIDs Non-Steroidal Anti-Inflammatory Drugs. Active disease when HAQ score > 0.5 and RAPID3 score ≥ 7
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us